Translational Genomics of Diabetes
La Nouvelle Orleans Ballroom C
Level 2, Ernest N. Morial Convention Center
Q&A with Anna L. Gloyn, DPhil
Professor of Pediatrics and, by courtesy, Genetics,
Stanford University
What is your presentation about?
My presentation will describe our work investigating a fascinating transcription factor which has important roles in multiple tissues which are key to governing metabolism. We have evidence from human genetics that altering expression and/or function of this protein influences risk for type 2 diabetes and a range of metabolic traits. Our work has investigated why this is the case.
What makes this topic important in 2022?
Human genetics has delivered hundreds of regions of the genome which are implicated in diabetes risk. The excitement now is that we are starting to really get to the bottom of what these tell us about fundamental biology.
How did you become involved with this area of diabetes research or care?
I got interested in diabetes and genetics during my undergraduate studies on account of a fantastic biochemistry teacher and a best friend with diabetes.
What are you most looking forward to at the 82nd Scientific Sessions?
I am really excited about meeting my colleagues in 3D and networking! I can’t wait to see colleagues who I’ve only seen on a Zoom screen for the last two years.
[sub-post-content]